Jacob Smeltzer is an Oncology physician affiliated with Saint Luke's East Hospital. OpenAlex indexes 16 publications with 286 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
110 NE Saint Lukes Blvd Ste 500
Lees Summit, MO 640866075
Telephone
816-287-6060Provider last certified this registry record 12 Mar 2025.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20251 payment
- PFIZER INC.Program year20241 payment
- Karyopharm Therapeutics Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
36.3%Aromatase Inhibitor13.3%Anastrozole81%Letrozole11%Exemestane9%Part D<11 patientsEstrogen Agonist/Antagonist5.9%Tamoxifen Citrate100%Part D≥23 patients+ 6 more classes in this area
Nervous system
19.1%Opioid Agonist6.2%Tramadol Hcl52%Oxycodone Hcl27%Morphine Sulfate Er21%Part D<11 patientsSSRI3.7%Escitalopram Oxalate58%Trazodone Hcl42%Part D<11 patients+ 4 more classes in this area
Metabolism & gastrointestinal
16.3%Potassium supplement5.2%Potassium Chloride100%Part D≥17 patientsSerotonin-3 Receptor Antagonist3.8%Ondansetron Hcl100%Part D≥29 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Epstein-Barr Virus Infection in an Elderly Nonimmunocompromised Adult Successfully Treated with Rituximab
Case Reports in Hematology
2014 - Secondary Hemophagocytic Syndrome Associated with Richter’s Transformation in Chronic Lymphocytic Leukemia
Case Reports in Hematology
2014
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”